HealthCapital Berlin Brandenburg

digitalHealthCapital@DMEA2026

20–24 Apr 2026 | Berlin, Germany

Register
Register
Register

InvestmentUpdated on 19 January 2026

ZenZen: The Future of Digital Therapeutics in Maternal Health

Co-Founder, UX Designer at ZenZen Diabetes Support

Berlin, Germany

About

ZenZen is an AI-driven health platform on a mission to break the diabetes development circle. By combining nurse-led clinical insights with proprietary AI, we are evolving from a support companion into a regulated Digital Therapeutic (DTx). We are now seeking a €600k seed investment to triple our target market by providing metabolic screening and therapy for all pregnancies.

🌟 Current Market Validation (Product-Market Fit)

We have already built a high-trust, scalable infrastructure that is currently live in 7 countries across 4 languages:

  • 🥗 Adaptive AI Meal Planner: A proprietary engine that learns from user preferences and glycemic responses to provide personalized nutrition.

  • 🤖 24/7 Conversational AI: An empathetic digital assistant providing real-time guidance and reducing patient anxiety.

  • 📊 Low-Friction Tracking & Knowledge Hub: A clinical-grade suite (85% ORCHA score) that ensures high user retention and data accuracy.

  • Traction: 150+ active users, Fit4Start Graduate, and recipient of a €60k grant from the Luxembourg government.

🚀 The Seed Vision: Scaling to a 360° DTx Ecosystem

The €600k investment will fund our transition into a high-barrier-to-entry medical diagnostic tool, expanding our reach from high-risk management to universal pregnancy screening.

🔬 Proprietary Diagnostics & Screening We are moving diagnostics from the clinic to the home to capture the market earlier:

  • Voice-Based Biomarkers: Utilizing AI to detect metabolic distress through subtle vocal changes—a non-invasive, high-margin screening tool.

  • Home Oral Glucose Testing: Integrated at-home diagnostic kits that feed real-time data directly into our clinical dashboard.

  • Early Detection Protocols: Identifying risks weeks before traditional clinical windows.

🏥 Monetization & Ecosystem Expansion

  • Integrated Telehealth: Direct in-app specialist consultations, creating a seamless referral loop.

  • Maternal Marketplace: A curated B2C revenue stream for medical devices and specialized nutritional products.

  • Prescribable DTx: Moving toward "Digital Health Application" status to unlock insurance reimbursement and clinical prescription.

💰 Investment Opportunity

  • Target: €600k Seed Round

  • Objective: Secure DTx certification, finalize voice-biomarker IP, and scale to 10k+ users.

  • Regulatory Lead: 85% ORCHA score and the CE mark provide a significant head start in the EU regulatory landscape.

Organisation

ZenZen Diabetes Support

Startup

Berlin, Germany

Similar opportunities